Clinical Trials Logo

Inguinal Hernia clinical trials

View clinical trials related to Inguinal Hernia.

Filter by:

NCT ID: NCT05091853 Active, not recruiting - Surgery Clinical Trials

Laparscopic Inguinal Hernia Repair - Does the Choice of Self-fixated Mesh Matter?

Start date: May 9, 2021
Phase: N/A
Study type: Interventional

Self-fixed mesh and postoperative pain after laparoscopic inguinal hernia surgery, a randomized clinical trial

NCT ID: NCT05088824 Not yet recruiting - Inguinal Hernia Clinical Trials

When and Why Desarda Repair

Start date: January 1, 2022
Phase:
Study type: Observational

One of the most significant subjects studied in abdominal wall surgery is inguinal hernia. Its management is very codified. The main factors evaluating efficient hernia surgery are not only the rate of complications (recurrence and groin pain essentially) but also cost and time to return to normal activities. Desarda technique is a non-mesh technique described first in 2001. This surgical technique uses a flap of external oblique aponeurosis in place of a mesh. Its singularity remains its low cost, no use of mesh, and less extensive dissection Mesh repair has its own limitations; it is unphysiological as mesh is used. Chronic inguinal pain, seroma formation, foreign body sensation, risk of mesh infection are common complications and not recommended in strangulated hernias and extra cost involved by the mesh itself. It involves use of undetached strip of external oblique aponeurosis to strengthen the posterior wall of the inguinal canal which is based on the physiological principles. This is a physiological repair and is tension free, can be used in strangulated hernia. Recurrence and complication rates equal to or less than Lichtenstein's repair. It's a simple procedure, early ambulation and less time of hospital stay, low cost for the patient as mesh is not used and most importantly no question of mesh related complications such as mesh rejection, infection, migration and foreign body sensation and chronic groin pain which is comparatively low in this procedure.

NCT ID: NCT05072171 Active, not recruiting - Inguinal Hernia Clinical Trials

Evidence of Myogenic Growth Factors in 3D Dynamic Inguinal Hernia Scaffold ProFlor

HERNIA
Start date: January 1, 2013
Phase:
Study type: Observational

The study utilizes the same tissue specimens gathered for previous investigations and removed from 15 patients already operated for inguinal hernia, who for different reasons needed additional surgery in the previously operated groin.

NCT ID: NCT05070572 Enrolling by invitation - Inguinal Hernia Clinical Trials

Measuring Intraabdominal Pressure, Lactic Acid, and Urine Output

Start date: January 1, 2021
Phase:
Study type: Observational

This study serves as a pilot study with the intention to to measure intraabdominal pressure, lactic acid, and urine output in obese individuals undergoing laparoscopic inguinal hernia repair. By measuring these values, the investigators aim to look for correlations between metrics and determine an accurate and precise measurement of IAP during laparoscopic hernia surgery using the Accuryn Monitoring System. By obtaining accurate and precise measurements of IAP during surgery the investigators will be to compare measurements to previous IAP data obtained during daily activities and strenuous movements and any associations with inguinal hernia recurrence.

NCT ID: NCT05069142 Completed - Inguinal Hernia Clinical Trials

Peri-Operative Rehab Program for Inguinal Hernia Repair Surgery

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Inguinal hernia repair is one of the most common surgeries, with more than 20 million performed globally each year. It is estimated that approximately 15% of patients undergoing inguinal hernia repair will experience persistent post-surgical pain that could last months to years. Evidence from related procedures indicates that better surgical preparation through pre-operative exercise and education (i.e. Prehabilitation) followed by ongoing post-surgical rehabilitation leads to more rapid recovery, return to activities and lower likelihood of persistent post-surgical pain. The investigators will determine the feasibility of a peri-operative rehabilitation program (pre- and post-surgery) and our study protocol for patients undergoing inguinal hernia repair surgery. The investigators hypothesize that: 1) our peri-operative intervention will be feasible and safe to undertake within a clinical setting; 2) adequate numbers will be enrolled to justify a larger trial; and that 3) our outcome measurement protocol will provide meaningful information with high response rate and low attrition after 3 months.

NCT ID: NCT05058378 Recruiting - Inguinal Hernia Clinical Trials

Correlation Between Spinal Anesthesia and Perfusion Index

Start date: September 20, 2021
Phase:
Study type: Observational

Investigation of the correlation between the success of obtaining unilateral spinal anesthesia and the measurement of perfusion index (pi).

NCT ID: NCT05011786 Completed - Inguinal Hernia Clinical Trials

Open and Laparoscopic Hernia Repair. A Comparative Study

Start date: January 1, 2017
Phase:
Study type: Observational

A retrospective comparative study in a pediatric surgery center to compare the outcomes of 2 approaches of hernia repair in the pediatric population.

NCT ID: NCT04891601 Completed - Inguinal Hernia Clinical Trials

Mesh Alone VS Combined Mesh and Darn in the Management of Primary Inguinal Hernia in Adult Males

Start date: January 2015
Phase: N/A
Study type: Interventional

A prospective randomized study involved 228 individuals with primary inguinal hernia, operated in our departments, between January 2015 to February 2018. The duration of hospital stay, operative time, duration of returning to routine activities, postsurgical sequels and recurrence rates estimated. We randomly allocated it into two groups: mesh repair was applied to 166 patients (Group 1) and combined both mesh, and darn repair applied to 162 patients (Group 2).

NCT ID: NCT04888078 Completed - Inguinal Hernia Clinical Trials

Bassini Inguinal Hernia Repair: Obsolete Or Still A Viable Surgical Option?

Start date: January 1, 2006
Phase:
Study type: Observational

Retrospective review of hernia surgery patients at HHMcGuire VAMC focusing on repair type and postoperative complications.

NCT ID: NCT04875598 Not yet recruiting - Postoperative Pain Clinical Trials

COMPARISON OF LAPAROSCOPY AND ULTRASOUND ASSISTED TRANSVERSUS ABDOMINIS PLANE BLOCK METHODS IN LAPAROSCOPIC TOTAL EXTRAPERITONEAL HERNIA REPAIR

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

While the rate of inguinal hernia repair operations in England is 10 per 100,000 people. The rate in the United States is found to be 28 per 100,000 people. Today, the effectiveness between open repair and laparoscopic repair in inguinal hernia repair is still debated. Laparoscopic approach offers many advantages over open repair. Regional blocks have an important place in the multi-modal anesthesia approach applied to reduce postoperative pain. In this sense, the Transversus Abdominis Plane Block (TAPB) emerges as an effective regional anesthesia method that reduces postoperative pain. This method can be applied with the help of ultrasound or laparoscopy. The aim of this study is to compare the ultrasound-assisted TAPB application and Laparoscopy-assisted TAPB application in Total Extraperitoneal hernia repair (TEP) to reveal the effects of postoperative pain. A total of 60 patients will be included in the study; 30 of these patients will be injected with local anesthetic into the fascia between the transversus abdominis and internal oblique muscles with the help of ultrasound from the designated area (Before the operation starts, TAPB with 20 ml 0.25 % bupivacaine will be applied to the surgical side under ultrasonography); In the other 30 patients, local anesthetic injection will be made to the same area under laparoscopic direct vision. 50 mg Bupivacaine (0.25 % 20 ml bupivacaine solution) has been determined as the application dose and this amount will be applied in both groups. 10 cm visual analog scale (VAS) will be used in postoperative pain follow-up. 50 mg intravenous tramadol will be administered to patients with VAS > 4 and tramadol will be supplemented to 100 mg in patients with high pain levels after 30 minutes. Oral non-steroidal anti-inflammatory will be given at the postoperative 8th hour. Patients whose pain persists despite current therapy will be given 25 mg of meperidine intravenously as a rescue analgesic. The doses of analgesic administered in the postoperative period and the hours of administration will be recorded